Denka Seiken to Construct Influenza Vaccine Manufacturing Facility in Niigata.Tokyo Tokyo (tō`kēō), city (1990 pop. 8,163,573), capital of Japan and of Tokyo prefecture, E central Honshu, at the head of Tokyo Bay. , Japan, May 2, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Denka Seiken will construct a facility for manufacturing influenza vaccine influenza vaccine Flu vaccine A vaccine recommended for those at high risk for serious complications from influenza: > age 65; Pts with chronic diseases of heart, lung or kidneys, DM, immunosuppression, severe anemia, nursing home and other chronic-care on the premises of its Niigata Plant. The company plans to begin constructing the new 4 billion yen ($35.0 mil An Internet address domain name for a military agency. See Internet address. (networking) mil - The top-level domain for entities affiliated with US armed forces. ) facility in May. Completion is slated for April 2007. The new facility, which will have an annual output capacity of 10 million units, will be operational in 2009. In addition, the company plans to proceed with research on tissue culture methods for influenza vaccine at the new facility. With this move, the company aims to meet a growing demand for influenza vaccines worldwide. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion